Evidence map›Paper›PMID 33976998›Full record

ArticleCureus2021

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test.

Eugene C Nwankwo, Jefferson Lines, Sahiba Trehan, Michelle Marsh, Amit Trehan, Kuldip Banwait, Srinivas Pathapati, Subhasis Misra, Izi Obokhare

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Eugene C NwankwoInternal Medicine, Saint Louis University, Saint Louis, USA.
Jefferson LinesGeneral Surgery, Texas Tech University Health Sciences Center, Amarillo, USA.
Sahiba TrehanGeneral Surgery, Texas Tech University Health Sciences Center, Amarillo, USA.
Michelle MarshGeneral Surgery, Texas Tech University Health Sciences Center, Amarillo, USA.
Amit TrehanGastroenterology, Amarillo Endoscopy Center, Amarillo, USA.
Kuldip BanwaitGastroenterology, Panhandle Gastroenterology, Amarillo, USA.
Srinivas PathapatiGastroenterology, Amarillo Endoscopy Center, Amarillo, USA.
Subhasis MisraSurgery, Oncology, Texas Tech University Health Sciences Center, Amarillo, USA.
Izi ObokhareGeneral Surgery, Texas Tech University Health Sciences Center, Amarillo, USA.
Saint Louis University · USTexas Tech University · USAmarillo College · USPanhandle Eye Group · USSaint Louis University · ESTexas Tech University Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background There is limited knowledge about adenoma detection rates (ADRs) in patients with a positive fecal immunochemical test (FIT). We hypothesized that colonoscopy performed after FIT would result in higher ADRs. Methods We reviewed ADRs for colonoscopies performed after a positive FIT test and compared them to ADR rates for routine colonoscopy performed without an initial FIT test between November 2014 and March 2017 at multiple endoscopy sites. Results A total of 979 patients underwent a FIT testing in the Texas panhandle, of whom 12.1% (n=119) tested positive. Also, 32.8% (n=39) were found to have one or more tubular adenomatous polyps on final pathological examination. Among these patients, the majority were female (64.1%; n=25). Of the patients, 15.9% (n=19) had a hyperplastic polyp, 1.7% (n=2) had findings consistent with ulcerative colitis, and 0.8% (n=1) were positive for an adenocarcinoma. In the control group of 2,603 patients in whom routine colonoscopy was performed as the initial tool for screening, 719 were found to have one or more tubular adenomas, with an ADR rate of 27.5%. In this group, the cancer rate was found to be 1%. Conclusions There was a significant increase in the ADR when colonoscopy is conducted after a positive FIT test. Recommending colonoscopies after a positive FIT test will not only improve ADRs significantly but also lower the overall healthcare cost for screening colon cancer in this era of escalating healthcare costs.

Indexed as

adrcolon cancer preventioncolonoscopy and polypectomyhealth care disparitieshyperplastic polypquantitative fit testuninsured patients

Identifiers

PMID33976998
PMCPMC8106918
OpenAlexW3156342233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.